RE: From Mike8 Nov 2021 11:44
From the company statement prior to last year's AGM;
"Business Development
A swift and proactive approach ensured that Quadrise has been able to mitigate, to a significant extent, the impact of COVID-19 on its business development and project activities. As a result, Quadrise continues to build positive momentum and demonstrate significant progress in several key areas.
Morocco. As announced on 26 October 2020, following the completion of the Pilot Trial at one of the client's industrial facilities in Morocco, work has continued on the phase 2 study and planning for the larger industrial-scale trial at another of the client's facilities in Morocco that is being carried out under an amendment to the original agreement. The phase 2 study and the industrial-scale trial are scheduled to be completed in Q1 2021, for which QFI will be paid £100,000. Pending a positive outcome, a new agreement will be finalised for the phase 2 trial that is being planned for Q2 2021 and is the final precursor to commercial roll-out. The purpose of the industrial trial is to de-risk commercial roll-out and fast-track the phase 2 trial, which is similar in scale and will utilise the same MSAR® trial equipment currently being assembled by Quadrise."
How they can reconcile the above two paragraphs to where we are now 12 months later will beggar belief. Proactive action to reduce Covid implications? yet 1-year later we learn there has been little or no progress. Let's hope the Institutional Investors now on board can demand answers as to why? Let's hope Mike Kirk's replacement can drive the projects forward with a bit more urgency, (I know Indigo, it depends on the client) especially in Morocco where they have already told us the client was very eager to progress things after the initial trial!!!